Tolerx Named as One of the 'Fierce 15' Biotech Compani...(ceutical company engaged in the discover...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Tolerx Named as One of the 'Fierce 15' Biotech Companies of 2008
Date:6/24/2008
ceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. Tolerx currently has two antibodies in clinical development for the potential treatment of various autoimmune indications: otelixizumab, an anti-CD3 MAb which is being developed in collaboration with GlaxoSmithKline and a modified form of TRX1, which is being developed in collaboration with Genentech, Inc. Tolerx is also engaged in preclinical development of new product candidates that circumvent immune system tolerance. These product candidates are being evaluated for the treatment of cancer or chronic viral diseases. For more information, please visit http://www.tolerx.com.
Tolerx Forward-Looking Statements
This press release contains certain statements that include the word
"potential". Such statements, which are not historical facts, constitute
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995 (the "Reform Act"). Statements regarding
outcomes sought to be realized in the clinical trials or preclinical
development, and the potential for Tolerx to make a significant impact in
the biotech market are all forward-looking statements. Such forward-looking
statements involve risks, uncertainties and other factors that may cause
the actual performance or achievements of Tolerx to be materially different
from any future results, performance, or achievements expressed or implied
by such forward-looking statements. There can be no certainty that Tolerx
will advance any clinical candidate or other component of its pipeline to
the clinic, to the next regulatory step or to commercialization or that
Tolerx will ever realize revenue from commercialization of product
candidates it is currently or may in the future seek to develop. Factors
and risks that may impact management's expectations and affect the
forward-looking statements include but are not be limit
'/>"/>
| SOURCE Tolerx, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
2. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
3. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
4. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
5. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
6. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
7. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
8. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
9. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
10. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
11. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
Post Your Comments:
Breaking Biology Technology:Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2
[0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer[0] New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
Other Biology Technology:Cadus Reports First Quarter 2008 Results 2Cadus Reports First Quarter 2008 Results 3Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress 2MedQuist and StructuRad Form Partnership to Integrate Report Macros into SpeechQ for Radiology(TM) 2
Cadus Reports First Quarter 2008 ResultsForest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual CongressMedQuist and StructuRad Form Partnership to Integrate Report Macros into SpeechQ for Radiology(TM)
Breaking Biology News(10 mins):Newly discovered mechanism allows cells to change state 2Tropical birds waited for land crossing between North and South America: UBC study 2Charlotte Cowan MD Honored by Obama Administration for Innovative Doctor Hippo Series of Childrens Books 50571 1Charlotte Cowan MD Honored by Obama Administration for Innovative Doctor Hippo Series of Childrens Books 50571 2Charlotte Cowan MD Honored by Obama Administration for Innovative Doctor Hippo Series of Childrens Books 50571 3Charlotte Cowan MD Honored by Obama Administration for Innovative Doctor Hippo Series of Childrens Books 50571 4Possible Gene Regions for Schizophrenia Located 50567 1Possible Gene Regions for Schizophrenia Located 50567 2Two Flight Surgeons Supporting Wyles Bioastronautics Contract Selected for New Astronaut Class 50563 1Two Flight Surgeons Supporting Wyles Bioastronautics Contract Selected for New Astronaut Class 50563 2Two Flight Surgeons Supporting Wyles Bioastronautics Contract Selected for New Astronaut Class 50563 3
Other Biology News:Growing nerve cells in 3-D dramatically affects gene expression 2A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2Study of protein folds offers insight into metabolic evolution 2Study of protein folds offers insight into metabolic evolution 3
Biology Products:
CyScribe First-Strand cDNA Labeling Kit with CyScribe GFX Purification Kit from GE Healthcare, formerly Amersham BiosciencesCyScribe Post-Labeling Kit with CyScribe GFX Purification Kit from GE Healthcare, formerly Amersham BiosciencesCanine serum from Equitech-BioUV-NIR light source for USB2000, HR4000, HR2000+ from Ocean Optics
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |